Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | EML4 |
| Upstream (Parents) |
|---|
| (<<) CASKIN1 → EML4 |
| (<<) COIL → EML4 |
| (<<) EIF2C2 → EML4 |
| (<<) HIPK1 → EML4 |
| (<<) KRAS → EML4 |
| (<<) NFAT5 → EML4 |
| (<<) NFKBIZ → EML4 |
| (<<) NRIP1 → EML4 |
| (<<) PDPK1 → EML4 |
| (<<) PLCD3 → EML4 |
| (<<) SLC20A1 → EML4 |
| (<<) TNFRSF10A → EML4 |
| (<<) WASF2 → EML4 |
| (<<) WBP4 → EML4 |
| (<<) ZNF224 → EML4 |
| Downstream (Children) |
|---|
| EML4 → CDK6 (>>) |
| EML4 → DDX18 (>>) |
| EML4 → DYNC1LI2 (>>) |
| EML4 → EGFR (>>) |
| EML4 → ENC1 (>>) |
| EML4 → FHIT (>>) |
| EML4 → IL1R2 (>>) |
| EML4 → KCNJ2 (>>) |
| EML4 → KCNK1 (>>) |
| EML4 → KLF7 (>>) |
| EML4 → LOC284542 (>>) |
| EML4 → LYAR (>>) |
| EML4 → MAP1B (>>) |
| EML4 → MAP3K3 (>>) |
| EML4 → MAP3K5 (>>) |
| EML4 → MAPK11 (>>) |
| EML4 → NFKBIA (>>) |
| EML4 → NMNAT1 (>>) |
| EML4 → NOL9 (>>) |
| EML4 → PRKCI (>>) |
| EML4 → SLC25A37 (>>) |
| EML4 → SOS1 (>>) |
| EML4 → SOX2 (>>) |
| EML4 → SYK (>>) |
